CC(=O)Nc1ccc(/C=C/C(=O)c2sc(-c3nc(C)c(C(=O)/C=C/c4ccc(NC(C)=O)cc4)s3)nc2C)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?